Trevi Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Trevi Therapeutics (TRVI) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Trevi Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Trevi Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Trevi Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $42k | 31k | 1.34 |
| 2023-09-30 | $49k | 23k | 2.18 |
| 2023-06-30 | $58k | 24k | 2.39 |
| 2023-03-31 | $14k | 7.6k | 1.85 |
| 2022-12-31 | $6.0k | 3.1k | 1.93 |
| 2022-09-30 | $7.0k | 4.3k | 1.64 |
| 2022-06-30 | $13k | 4.8k | 2.72 |
| 2022-03-31 | $4.0k | 1.6k | 2.46 |
| 2021-09-30 | $7.0k | 5.2k | 1.35 |
| 2021-06-30 | $5.0k | 2.1k | 2.34 |
| 2021-03-31 | $6.0k | 2.4k | 2.52 |
| 2020-03-31 | $2.0k | 541 | 3.70 |
| 2019-09-30 | $7.0k | 1.6k | 4.44 |
| 2019-06-30 | $14k | 1.9k | 7.29 |